Menu Search
Equities

PharmChem Inc

PCHM:PKC

PharmChem Inc

Actions
  • Price (USD)3.62
  • Today's Change0.00 / 0.00%
  • Shares traded8.00
  • 1 Year change+38.17%
  • Beta0.7466
Data delayed at least 15 minutes, as of Sep 13 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year PharmChem Inc had net income fall -16.95% from 870.43k to 722.89k despite a 3.50% increase in revenues from 5.84m to 6.04m. An increase in the selling, general and administrative costs as a percentage of sales from 45.65% to 50.27% was a component in the falling net income despite rising revenues.
Gross margin64.49%
Net profit margin19.05%
Operating margin22.94%
Return on assets34.87%
Return on equity43.21%
Return on investment42.91%
More ▼

Cash flow in USDView more

In 2023, cash reserves at PharmChem Inc fell by 1.71m. However, the company earned 638.89k from its operations for a Cash Flow Margin of 10.57%. In addition the company used on investing activities and also paid 2.35m in financing cash flows.
Cash flow per share0.24
Price/Cash flow per share14.75
Book value per share0.5903
Tangible book value per share0.590
More ▼

Balance sheet in USDView more

PharmChem Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio5.49
Quick ratio5.20
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.